Delivery Order SPE2DB22D1017-SPE2DB25FG4RF

Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a ceiling value of $11,868.44 and a period of performance through April 11, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a prescription medication. The contract has a ceiling value of $30,447.93 and is a firm fixed-price delivery order with an ultimate completion date of May 29, 2025. The contract is not set-aside and is open to full and open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a ceiling value of $7,972.19. The contract is a firm fixed price, non-set-aside award with a completion date of May 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a ceiling value of $26,601.28 and a period of performance through May 30, 2025. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $8,843.70. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a prescription medication. The delivery order has a period of performance through May 8, 2025 and is a firm fixed-price contract. The contract is not set-aside for any particular business category. AmerisourceBergen Drug Corp holds a significant...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a ceiling value of $52,993.17 and a completion date of May 21, 2025. The contract is a firm fixed price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $16,243.70 and is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product. The delivery order has an ultimate completion date of June 11, 2025. AmerisourceBergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML. The contract has a ceiling value of $15,616.14 and runs through April 10, 2025. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a prescription medication, with a ceiling value of $71,899.05 and a performance period through May 2, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The firm-fixed-price contract has a ceiling value of $13,877.25 and a period of performance through March 19, 2025. The contract was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG4RF
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product. The contract has a ceiling value of $7,879.83 and a completion date of June 11, 2025. It is a firm fixed-price delivery order contract, indicating a set price for the requested products. The contract is not set-aside, meaning it was open to competition from all qualified vendors. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.

Generated 9/9/25, 12:49 PM